PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97469170 |
Filing Date: 06/21/2022 |
Input Field |
Entered |
SERIAL NUMBER | 97469170 |
---|---|
MARK INFORMATION | |
*MARK | \\TICRS\EXPORT18\IMAGEOUT 18\974\691\97469170\xml1 \ APP0002.JPG |
SPECIAL FORM | YES |
USPTO-GENERATED IMAGE | NO |
LITERAL ELEMENT | BELUGA CATHETER SYSTEM |
COLOR MARK | YES |
COLOR(S) CLAIMED (If applicable) |
The color(s) blue, white and yellow is/are claimed as a feature of the mark. |
*DESCRIPTION OF THE MARK (and Color Location, if applicable) |
The mark consists of the stylized words BELUGA CATHETER SYSTEM, with the word BELUGA in blue over the smaller words CATHETER SYSTEM in blue in a multi-dotted circular design in blue and yellow dots. |
PIXEL COUNT ACCEPTABLE | YES |
PIXEL COUNT | 700 x 700 |
REGISTER | Principal |
APPLICANT INFORMATION | |
*OWNER OF MARK | Graham Braswell Biotechnologies Inc. |
*MAILING ADDRESS | 150 Rivington Street, Apartment 3G |
*CITY | New York |
*STATE (Required for U.S. applicants) |
New York |
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
*ZIP/POSTAL CODE (Required for U.S. and certain international addresses) |
10002 |
PHONE | 212-549-0346 |
*EMAIL ADDRESS | XXXX |
LEGAL ENTITY INFORMATION | |
TYPE | corporation |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION | Delaware |
GOODS AND/OR SERVICES AND BASIS INFORMATION | |
INTERNATIONAL CLASS | 010 |
*IDENTIFICATION | Medical devices and apparatus, namely, catheter balloon inflation devices, drug coated balloon devices, dialysis catheters, covered stents, stent grafts, thrombectomy devices, thrombolysis devices, endovascular fistula creation devices, surgical fistula creation, or kidney transplant, to be used to treat end stage kidney disease via hemodialysis or peritoneal dialysis |
FILING BASIS | SECTION 1(b) |
ATTORNEY INFORMATION | |
NAME | Darren B. Cohen |
ATTORNEY DOCKET NUMBER | 400784.20002 |
ATTORNEY BAR MEMBERSHIP NUMBER | XXX |
YEAR OF ADMISSION | XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY | XX |
FIRM NAME | Reed Smith LLP |
STREET | 599 Lexington Avenue |
CITY | New York |
STATE | New York |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
ZIP/POSTAL CODE | 10022 |
PHONE | 212-549-0346 |
EMAIL ADDRESS | dcohen@reedsmith.com |
CORRESPONDENCE INFORMATION | |
NAME | Darren B. Cohen |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | dcohen@reedsmith.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | nycipdocketing@reedsmith.com |
FEE INFORMATION | |
APPLICATION FILING OPTION | TEAS Standard |
NUMBER OF CLASSES | 1 |
APPLICATION FOR REGISTRATION PER CLASS | 350 |
*TOTAL FEES DUE | 350 |
*TOTAL FEES PAID | 350 |
SIGNATURE INFORMATION | |
SIGNATURE | /Darren B. Cohen/ |
SIGNATORY'S NAME | Darren B. Cohen |
SIGNATORY'S POSITION | Attorney of Record, New York State Bar Member |
SIGNATORY'S PHONE NUMBER | 212-549-0346 |
DATE SIGNED | 06/21/2022 |
SIGNATURE METHOD | Signed directly within the form |
PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97469170 |
Filing Date: 06/21/2022 |
The applicant's current Correspondence Information: |
Darren B. Cohen |
PRIMARY EMAIL FOR CORRESPONDENCE: dcohen@reedsmith.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): nycipdocketing@reedsmith.com Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS). |
|
|